| Moffitt

Hematologist Trains at Moffitt, Hoping to Benefit Armenians

Through a visiting physician program, a doctor is learning the intricacies of an allogeneic BMT procedure and care to help his home country

Proper Oral Care for Cancer Patients Reduces Infections

Blood and marrow transplant and cellular immunotherapy patients have better comfort and outcomes, new research shows

High School Biology Lesson Inspires Decades-long Career as Bone Marrow Transplanter

Dr. Lia Perez is a hematologist and researcher who is an expert in allogeneic hematopoietic stem cell transplantation

Cellular Therapy May Be Viable Option for Advanced Melanoma Patients

Nearly one-third of patients respond to a single infusion of tumor infiltrating lymphocytes

Moffitt Cancer Center’s Clinical Trials Focus on Expansion, Diversity and Innovation

The cancer center offers one of the largest portfolios of clinical trials in the nation, with nearly 400 active treatment trials

Moffitt’s Newest Partnership to Advance Cell Therapies for Solid Tumors

Strategic alliance with Turnstone Biologics Corp. focuses on tumor infiltrating lymphocyte therapies

Can Gene-Edited CAR T Improve Non-Hodgkin Lymphoma Outcomes?

New product involves dual targeting, signaling technology and gene editing

Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner

Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care

Can Tumor Mutations Cause Resistance to Cellular Immunotherapy?

Moffitt study shows certain alterations can indicate poor outcomes for lymphoma patients receiving CAR T-cell therapy

New Donor Cell Transplant Treatment Shows Promise in Multiple Myeloma

Allogeneic hematopoietic cell transplantation can extend survival for patient when combined with chemotherapy

‘Off the Shelf’ CAR T Shows Promise

New study results find the therapy is effective for certain lymphoma patients

Moffitt Celebrates Cell Therapy Milestone

The cancer center infused its 500th patient with CAR T-cell therapy

Expanding CAR T to Adults with Acute Lymphoblastic Leukemia

New study results show cellular therapy could be an option for older patient population

Following the Science

Five of 10 researchers from MD Anderson joined Dr. Patrick Hwu at Moffitt

Moffitt CEO Focuses Research on Creating ‘Super Soldiers’

Hwu’s lab seeks out new T-cell therapies for some of the toughest cancers

FDA Approves CAR T to Help Patients with Relapsed Multiple Myeloma

For one patient, the therapy, made available to him through a clinical trial, was his last resort

Rethinking Cellular Immunotherapy

Moffitt study uses CAR T therapy to treat side effects of cancer therapy

Speeding Up Cellular Immunotherapy

New ‘off the shelf’ CAR T product shows promise in phase 1 study

An Immunotherapy Used to Treat Cancer May Help COVID-19 Patients

FDA approves clinical trials using cellular immunotherapy to battle the virus

Accidental Discovery Could Lead to Future Cancer Therapy

Researchers in Europe discover T cell that may help detect and kill several cancers

Bridging Therapy Not Recommended for All CAR T Patients

New data presented by Moffitt shows poorer outcome for patients who receive bridging therapy prior to CAR T-cell therapy.

Third Grade Friends Hold Bake Sale to Raise Money for Cancer Research

The two students mailed a handwritten note to Dr. Frederick Locke, the CAR T investigator at Moffitt, to "use the money we made at our bake sale to he ...

Endeavor^®

Filter Features Results

22 Articles Found